ACBD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.522100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.835000E-01
Normal-vs-Stage2
4.528300E-02
Normal-vs-Stage3
7.654200E-02
Normal-vs-Stage4
2.449000E-01
Stage1-vs-Stage2
3.960100E-02
Stage1-vs-Stage3
3.752000E-01
Stage1-vs-Stage4
1.882230E-01
Stage2-vs-Stage3
6.458800E-03
Stage2-vs-Stage4
3.795200E-01
Stage3-vs-Stage4
1.296050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.249700E-02
Normal-vs-AfricanAmerican
4.753400E-01
Normal-vs-Asian
9.108400E-02
Caucasian-vs-AfricanAmerican
6.376400E-01
Caucasian-vs-Asian
2.578000E-01
AfricanAmerican-vs-Asian
9.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.159900E-02
Normal-vs-Female
1.164560E-01
Male-vs-Female
5.629600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.644000E-01
Normal-vs-Age(41-60Yrs)
1.074370E-02
Normal-vs-Age(61-80Yrs)
1.568030E-01
Normal-vs-Age(81-100Yrs)
9.320800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.847000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.247600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.367200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.167440E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.924820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.669200E-01
Normal-vs-Daily Drinker
7.495900E-02
Normal-vs-Weekly Drinker
6.506000E-01
Normal-vs-Occasional Drinker
8.695500E-02
Normal-vs-Social Drinker
3.511200E-01
Non Drinker-vs-Daily Drinker
1.321220E-01
Non Drinker-vs-Weekly Drinker
3.262400E-01
Non Drinker-vs-Occasional Drinker
1.343370E-01
Non Drinker-vs-Social Drinker
5.929400E-01
Daily Drinker-vs-Weekly Drinker
4.369900E-02
Daily Drinker-vs-Occasional Drinker
7.588200E-01
Daily Drinker-vs-Social Drinker
2.798400E-01
Weekly Drinker-vs-Occasional Drinker
4.699800E-02
Weekly Drinker-vs-Social Drinker
1.849830E-01
Occasional Drinker-vs-Social Drinker
4.060000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.583600E-01
Normal-vs-Grade 2
1.633440E-01
Normal-vs-Grade 3
1.764380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.275800E-01
Grade 1-vs-Grade 3
8.891200E-01
Grade 1-vs-Grade 4
2.583600E-01
Grade 2-vs-Grade 3
6.455400E-01
Grade 2-vs-Grade 4
1.633440E-01
Grade 3-vs-Grade 4
1.764380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.801200E-01
Normal-vs-NonDiabetic
1.068370E-02
Diabetic-vs-NonDiabetic
1.770580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.426030E-01
Normal-vs-NoPancreatitis
5.727800E-02
Pancreatitis-vs-NoPancreatitis
3.070800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.970200E-01
Normal-vs-N1
3.468200E-02
N0-vs-N1
5.337400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.717800E-03
Normal-vs-TP53-NonMutant
7.892000E-01
TP53-Mutant-vs-TP53-NonMutant
1.197340E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
